Results
1
-
1
of
1
The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent
,
European Journal of Clinical Pharmacology
[DOI: 10.1007/s00228-012-1382-7]